BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29317071)

  • 1. Recently discovered interstitial cells "telocytes" as players in the pathogenesis of uterine leiomyomas.
    Varga I; Klein M; Urban L; Danihel L; Polak S; Danihel L
    Med Hypotheses; 2018 Jan; 110():64-67. PubMed ID: 29317071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of uterine telocytes and their architecture in leiomyoma.
    Aleksandrovych V; Białas M; Pasternak A; Bereza T; Sajewicz M; Walocha J; Gil K
    Folia Med Cracov; 2018; 58(3):89-102. PubMed ID: 30521514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Autonomic Innervation and Uterine Telocyte Interplay in Leiomyoma Formation.
    Aleksandrovych V; Kurnik-Łucka M; Bereza T; Białas M; Pasternak A; Cretoiu D; Walocha JA; Gil K
    Cell Transplant; 2019 May; 28(5):619-629. PubMed ID: 30841718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
    Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
    Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matricellular proteins in human uterine leiomyomas and normal myometrium.
    Bogusiewicz M; Semczuk A; Juszczak M; Langner E; Walczak K; Rzeski W; Tomaszewski J; Rechberger T
    Histol Histopathol; 2012 Nov; 27(11):1495-502. PubMed ID: 23018248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of bcl-2 protein in uterine leiomyomas and normal myometrium].
    Zhang ZL; Zhang Y; Xu BQ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):363-5. PubMed ID: 12536738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telocytes in the architecture of uterine fibroids.
    Aleksandrovych V; Pasternak A; Gil K
    Folia Med Cracov; 2019; 59(4):33-44. PubMed ID: 31904748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium.
    Mangrulkar RS; Ono M; Ishikawa M; Takashima S; Klagsbrun M; Nowak RA
    Biol Reprod; 1995 Sep; 53(3):636-46. PubMed ID: 7578688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium.
    Hou P; Zhao L; Li Y; Luo F; Wang S; Song J; Bai J
    Mol Hum Reprod; 2014 Feb; 20(2):148-54. PubMed ID: 24130091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex steroid hormone receptors of telocytes - potential key role in leiomyoma development.
    Aleksandrovych V; Gil A; Wrona A
    Folia Med Cracov; 2020 Sep; 60(2):81-95. PubMed ID: 33252597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12 Attracts Bone Marrow-Derived Cells to Uterine Leiomyomas.
    Moridi I; Mamillapalli R; Kodaman PH; Habata S; Dang T; Taylor HS
    Reprod Sci; 2020 Sep; 27(9):1724-1730. PubMed ID: 32020550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nonrandom regional distribution of uterine leiomyomas: a clue to histogenesis?
    Cramer SF; Patel A
    Hum Pathol; 1992 Jun; 23(6):635-8. PubMed ID: 1592385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium.
    Bogusiewicz M; Stryjecka-Zimmer M; Postawski K; Jakimiuk AJ; Rechberger T
    Gynecol Endocrinol; 2007 Sep; 23(9):541-6. PubMed ID: 17943549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Bcl-2, Bcl-x, Mcl-1, Bax and Bak in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.
    Wu X; Blanck A; Olovsson M; Henriksen R; Lindblom B
    J Steroid Biochem Mol Biol; 2002 Jan; 80(1):77-83. PubMed ID: 11867266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth.
    Asano R; Asai-Sato M; Miyagi Y; Mizushima T; Koyama-Sato M; Nagashima Y; Taguri M; Sakakibara H; Hirahara F; Miyagi E
    Am J Obstet Gynecol; 2015 Aug; 213(2):199.e1-8. PubMed ID: 25724399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment.
    Wu X; Blanck A; Olovsson M; Möller B; Lindblom B
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):497-504. PubMed ID: 11380284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance spectroscopy features of uterine leiomyomas.
    Celik O; Sarac K; Hascalik S; Alkan A; Mizrak B; Yologlu S
    Gynecol Obstet Invest; 2004; 58(4):194-201. PubMed ID: 15286450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium.
    Stewart EA; Austin DJ; Jain P; Penglase MD; Nowak RA
    Fertil Steril; 1996 Jun; 65(6):1119-24. PubMed ID: 8641483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of cyclooxygenase-2 in uterine fibroids and its correlation with cell proliferation.
    Ke X; Dou F; Cheng Z; Dai H; Zhang W; Qu X; Ding P; Zuo X
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):199-203. PubMed ID: 23398724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 14-3-3 protein family levels and associated receptor expression of estrogen and progesterone in human uterine leiomyomas.
    Wang L; Huang H; Liu D; Fang S; Xian Y; Zhou J; Zuo Y; Wang F; Huang O; He M
    Gynecol Endocrinol; 2012 Aug; 28(8):665-8. PubMed ID: 22329840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.